Acquisition-backed EpiphanyRx is now Navitus’ in-house bundled PBM solution for smaller groups (5,000 lives and below) after being acquired in 2021, signaling a stable platform for upsell to similarly sized employers seeking cost containment and dedicated service.

Cost-Containment Focus The company was founded to reduce rising prescription costs while delivering exceptional service, presenting a clear value proposition for mid-market employers facing budget pressures and seeking transparent pricing.

Small-to-Mid Market Target customers are employers with under 5,000 lives; this segment often has limited internal PBM expertise, creating opportunity for Navitus EpiphanyRx to position as a hands-on, fully bundled solution.

Strategic Partnerships Navitus’ ownership and integration of EpiphanyRx alongside ArchimedesRx indicates a broader ecosystem play in specialty drugs, offering cross-sell potential to clients needing both PBM services and specialty medication management.

Growth Narrative Publicized acquisition history and rebranding to Navitus signal a growth and scale story that can be used to engage prospects seeking a proven, enterprise-grade partner with experience in cost management and service quality.